The New Math Of IVF: One Equals Two

BASKING RIDGE, N.J., Oct. 20, 2015 /PRNewswire/ -- Reproductive Medicine Associates of New Jersey (RMANJ), a world-renowned leader in the field of infertility, continues to lead the industry in cutting-edge research, sharing 22 abstracts at the 71^st Annual American Society for Reproductive Medicine (ASRM) conference this week in Baltimore.

"I'm extremely proud of the new research being developed by RMANJ's team of physicians, scientists, and nurses – our entire group. Their unwavering commitment to excellence in reproductive endocrinology is pushing our field forward," said Richard T. Scott, Jr., M.D., F.A.C.O.G., H.C.L.D., laboratory director and a founding partner at RMANJ based in Basking Ridge, NJ.

Advancements in IVF over the last decade have led to a dramatic improvement in pregnancy rates. However, this has come with a marked increase in multiple gestations that often lead to profound health risks, emotional burdens and financial consequences for families and businesses.

"Multiple embryo transfer remains the one choice that some doctors and expectant parents make that may not be in the best interest of their family," said Marie Werner, M.D., F.A.C.O.G. based in RMANJ's Eatontown, NJ location. "Simply put, singleton pregnancies and deliveries could result in healthier moms and babies while potentially lowering costs for insurance companies if there was more education and insurance coverage for single embryo transfer with genetic screening."

Werner's research, titled One vs. Two: Patient Perspectives on Elective Single Embryo Transfer (eSET), being presented at ASRM's annual conference, finds that more than 70 percent of patients who had completed an embryo transfer would still prefer to deliver their children one at a time.

"Patients often choose double embryo transfers (DET) to increase their likelihood of becoming pregnant, but new research and techniques, including comprehensive chromosome testing (CCS) combined with eSET, maximize delivery rates while minimizing the risk of twins," continued Werner.

Research shows that when SET is combined with CCS the success rate is nearly 50 percent—this is double the 20 percent success rate of a healthy, fertile couple who is trying to conceive on their own every month. Because of this, insurance companies are beginning to look closely at this new approach as they discover that the cost of testing the embryos is significantly less than the cost that can be associated with twin gestations and births.

Additional research being shared by RMANJ physicians during the conference includes a look into what role microbiome plays during the time of transfer, the impact of endometriosis on aneuploidy and next-generation sequencing. 

ABOUT REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY

The experts at RMANJ offer IVF delivery rates of 60.8% in women under 35* (n=746/SART.org) which is above the US average.  Since 1999, they have helped bring more than 30,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ (www.reifellowship.com), the practice has 22 physicians and nine locations in New Jersey: Basking Ridge, Eatontown, Englewood, Freehold, Hamilton, Morristown, Short Hills, Somerset, and West Orange.

RMANJ pioneered and successfully implemented a cutting-edge technology known as Comprehensive Chromosome Screening (CCS) to more accurately detect healthy embryos that have led to successful pregnancies and ultimately healthy babies. Comprehensive Chromosome Screening (SelectCCS) is owned and operated by the Foundation for the Assessment and Enhancement of Embryonic Competence (www.faeec.org), and offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy. For more information, please call 973-656-2089 or visit www.rmanj.com.

*A comparison of clinic success rates may not be meaningful because patient medical characteristics, treatment approaches, and entry criteria for ART may vary from clinic to clinic. Please visit www.SART.org for more information.

SOURCE Reproductive Medicine Associates of New Jersey

Related Links

http://www.rmanj.com